Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001125282-05-004996
Filing Date
2005-09-28
Accepted
2005-09-28 17:22:25
Documents
7
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO ANNUAL REPORT b408971_10ka.txt 10-K/A 467853
2 EXHIBIT 12.1 b408971ex_12-1.txt EX-12.1 2423
3 EXHIBIT 23.0 b408971ex_23-0.txt EX-23.0 1516
4 EXHIBIT 31.1 b408971ex_31-1.txt EX-31.1 5454
5 EXHIBIT 31.2 b408971ex_31-2.txt EX-31.2 5448
6 EXHIBIT 32.1 b408971ex_32-1.txt EX-32.1 1946
7 EXHIBIT 32.2 b408971ex_32-2.txt EX-32.2 1927
  Complete submission text file 0001125282-05-004996.txt   488222
Mailing Address C/O DORSEY & WHITNEY LLP 250 PARK AVE NEW YORK NY 10177
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 7329804500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-12957 | Film No.: 051109092
SIC: 2836 Biological Products, (No Diagnostic Substances)